HFA Premium Access

Possibility of the CAVI as the risk factor of development of heart failure with preserved left ventricular ejection fraction

Congress Presentation

About the speaker

Doctor Koji Takagi

Momentum Research, Inc., Chapel Hill (United States of America)
0 follower

16 more presentations in this session

Effect of drug treatment on quality of life in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomised controlled trials

Speaker: Doctor S. Zheng (London, GB)


Prognostic impact of blood pressure values in patients with heart failure with preserved ejection fraction

Speaker: Doctor M. Goncalves (Viseu, PT)


Exercise training in diastolic heart failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial

Speaker: Doctor A. Feuerstein (Berlin, DE)


Left atrial volume index predicts major adverse cardiovascular events in patients with ischemic chronic heart failure with preserved ejection fraction and renal dysfunction

Speaker: Professor D. Lashkul (Zaporizhzhya, UA)


The comorbidity in patients with heart failure and preserved ejection fraction depending on age


Access the full session

Poster session 3 - HFpEF - Heart failure with preserved ejection fraction

Speakers: Doctor K. Takagi, Doctor S. Zheng, Doctor M. Goncalves, Doctor A. Feuerstein, Professor D. Lashkul

About the event


Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by